These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24345887)

  • 21. Inflammatory bowel disease in children: a pediatrician's perspective.
    Cuffari C
    Minerva Pediatr; 2006 Apr; 58(2):139-57. PubMed ID: 16835574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: Inflammatory bowel disease and genetics.
    Weersma RK; van Dullemen HM; van der Steege G; Nolte IM; Kleibeuker JH; Dijkstra G
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():57-65. PubMed ID: 18081650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To what extent are genetics clinically useful?
    Vermeire S
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S8-14. PubMed ID: 21640929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moving towards disease modification in inflammatory bowel disease therapy.
    Allen PB; Peyrin-Biroulet L
    Curr Opin Gastroenterol; 2013 Jul; 29(4):397-404. PubMed ID: 23695427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases.
    Ahmed FE
    Expert Rev Mol Diagn; 2006 May; 6(3):345-63. PubMed ID: 16706738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scoring systems in inflammatory bowel disease.
    Sehgal R; Koltun WA
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):513-21. PubMed ID: 20678023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.
    Eloranta JJ; Wenger C; Mwinyi J; Hiller C; Gubler C; Vavricka SR; Fried M; Kullak-Ublick GA;
    Pharmacogenet Genomics; 2011 Sep; 21(9):559-64. PubMed ID: 21832969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic markers in inflammatory bowel disease (IBD).
    Nakamura RM; Barry M
    MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics in diagnosing and managing inflammatory bowel disease.
    McCauley JL; Abreu MT
    Gastroenterol Clin North Am; 2012 Jun; 41(2):513-22. PubMed ID: 22500532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease.
    Klein W; Tromm A; Griga T; Fricke H; Folwaczny C; Hocke M; Eitner K; Marx M; Runte M; Epplen JT
    Electrophoresis; 2000 Nov; 21(17):3578-82. PubMed ID: 11271474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
    Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
    Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
    Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
    Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutrigenomics and nutrigenetics in inflammatory bowel diseases.
    Gruber L; Lichti P; Rath E; Haller D
    J Clin Gastroenterol; 2012 Oct; 46(9):735-47. PubMed ID: 22941427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand?
    Fiocchi C
    Dig Dis; 2009; 27(3):226-35. PubMed ID: 19786745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
    Dring MM; Goulding CA; Trimble VI; Keegan D; Ryan AW; Brophy KM; Smyth CM; Keeling PW; O'Donoghue D; O'Sullivan M; O'Morain C; Mahmud N; Wikström AC; Kelleher D; McManus R
    Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.